Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Total Liabilities (2016 - 2025)

iBio (IBIO) has disclosed Total Liabilities for 15 consecutive years, with $7.8 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities changed 0.4% to $7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.8 million through Dec 2025, changed 0.4% year-over-year, with the annual reading at $8.3 million for FY2025, 12.08% up from the prior year.
  • Total Liabilities for Q4 2025 was $7.8 million at iBio, down from $8.1 million in the prior quarter.
  • The five-year high for Total Liabilities was $43.2 million in Q3 2021, with the low at $6.8 million in Q3 2024.
  • Average Total Liabilities over 5 years is $23.9 million, with a median of $25.6 million recorded in 2023.
  • The sharpest move saw Total Liabilities crashed 72.36% in 2024, then increased 20.01% in 2025.
  • Over 5 years, Total Liabilities stood at $35.8 million in 2021, then fell by 8.01% to $33.0 million in 2022, then fell by 24.72% to $24.8 million in 2023, then crashed by 68.57% to $7.8 million in 2024, then grew by 0.4% to $7.8 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $7.8 million, $8.1 million, and $8.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.